Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Folotyn (Allos)
- INDICATIONS: Relapsed or refractory peripheral T-cell lymphoma
- CLASS: Folate analogue metabolic inhibitor
- HALF-LIFE: 12–18 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
BCG Vaccine, Cardiac glycosides, Denosumab, Echinacea, Leflunomide, Meloxicam, Natalizumab, NSAIDs, Pimecrolimus, Probenecid, Roflumilast, Salicylates, Sapropterin, Sipuleucel-T, Sulfamethoxazole, Tacrolimus, Trastuzumab, Trimethoprim, Vaccines, Vitamin K antagonists
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
